Given the very different transcriptional program enacted by ERα and ERβ (reviewed in5 it is potentially significant for the underlying biology to consider that the impact of aromatase may differ depending on the dominant oestrogen receptor present in the individual carcinoma. The gene discussed is CYP19A1; the disease is carcinoma.